Novel factors as therapeutic targets to treat diabetes. Focus on leptin and ghrelin

Expert Opinion on Therapeutic Targets

Volumn 13, Issue 5, 2009, Pages 583-591

  Gómez, Rodolfo ^a   Lago, Francisca ^a   Gómez Reino, Juan J ^a   Gualillo, Oreste ^a  

^a Instituto de Salud Carlos III   (Spain)

Author keywords

Adipokines; Diabetes; Ghrelin; Leptin; Obesity

Indexed keywords

ADIPOCYTOKINE; GHRELIN; LEPTIN;

DIABETES MELLITUS; GLUCOSE METABOLISM; HUMAN; LIPODYSTROPHY; LIVER; METABOLIC DISORDER; NONHUMAN; PANCREAS; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ADULT; ANIMALS; CHILD; DIABETES MELLITUS, TYPE 2; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; ENERGY METABOLISM; FEMALE; GHRELIN; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; ISLETS OF LANGERHANS; LEPTIN; MICE; MICE, KNOCKOUT; OBESITY; RECEPTORS, GHRELIN; RECEPTORS, LEPTIN;

EID: 67649619567     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728220902914834     Document Type: Review

References (115)

1. Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372(6505):425-432 · First description of cloning and identification of leptin in mice.
2. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000;11(8):327-332
3. Hube F, Lietz U, Igel M, et al. Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans. Horm Metab Res 1996;28(12):690-693
4. Montague CT, Prins JB, Sanders L, et al. Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes 1997;46(3):342-347
5. Ahima RS, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996;382(6588):250-252
6. Kolaczynski JW, Nyce MR, Considine RV, et al. Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro. Diabetes 1996;45(5):699-701
7. Boden G, Chen X, Mozzoli M, et al. Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 1996;81(9):3419-3423
8. Zakrzewska KE, Cusin I, Sainsbury A, et al. Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance. Diabetes 1997;46(4):717-719
9. Margetic S, Gazzola C, Pegg GG, et al. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 2002;26(11):1407-1433
10. Chua SC Jr, Chung WK, Wu-Peng XS, et al. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 1996;271(5251):994-996
11. Lee GH, Proenca R, Montez JM, et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996;379(6566):632-635
12. Otero M, Lago R, Gomez R, et al. Towards a pro-inflammatory and immunomodulatory emerging role of leptin. Rheumatology (Oxford) 2006;45(8):944-950
13. Lepercq J, Catalano P, Hauguel de Mouzon S. [Leptin in pregnancy: facts, questions and future]. Gynecol Obstet Fertil 2007;35(2):89-95. [Article in French]
14. Patel SB, Reams GP, Spear RM, et al. Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease. Curr Hypertens Rep 2008;10(2):131-137
15. Lago F, Dieguez C, Gomez-Reino J, et al. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev 2007;18(3-4):313-325
16. Karsenty G. Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab 2006;4(5):341-348
17. Friedman JM. The function of leptin in nutrition, weight, and physiology. Nutr Rev 2002;60(10 Pt 2):S1-14; discussion S68-84, 85-87 · A detailed and well-thought review focussed on leptin biological activity.
18. Morioka T, Asilmaz E, Hu J, et al. Disruption of leptin receptor expression in the pancreas directly affects β cell growth and function in mice. J Clin Invest 2007;117(10):2860-2868
19. Elefteriou F, Ahn JD, Takeda S, et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 2005;434(7032):514-520
20. Yildiz BO, Haznedaroglu IC. Rethinking leptin and insulin action: therapeutic opportunities for diabetes. Int J Biochem Cell Biol 2006;38(5-6):820-830
21. Pelleymounter MA, Cullen MJ, Baker MB, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995;269(5223):540-543
22. Levin N, Nelson C, Gurney A, et al. Decreased food intake does not completely account for adiposity reduction after ob protein infusion. Proc Natl Acad Sci U S A 1996;93(4):1726-1730
23. Shimomura I, Hammer RE, Ikemoto S, et al. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999;401(6748):73-76
24. Minokoshi Y, Kim YB, Peroni OD, et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 2002;415(6869):339-343
25. Havel PJ, Kasim-Karakas S, Mueller W, et al. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab 1996;81(12):4406-4413
26. Moriya M, Okumura T, Takahashi N, et al. An inverse correlation between serum leptin levels and hemoglobin A1c in patients with non-insulin dependent diabetes mellitus. Diabetes Res Clin Pract 1999;43(3):187-191
27. Carantoni M, Abbasi F, Azhar S, et al. Can changes in plasma insulin concentration explain the variability in leptin response to weight loss in obese women with normal glucose tolerance? J Clin Endocrinol Metab 1999;84(3):869-872
28. Segal KR, Landt M, Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 1996;45(7):988-991
29. Mantzoros CS, Moschos S, Avramopoulos I, et al. Leptin concentrations in relation to body mass index and the tumor necrosis factor-α system in humans. J Clin Endocrinol Metab 1997;82(10):3408-3413
30. Fox C, Esparza J, Nicolson M, et al. Plasma leptin concentrations in Pima Indians living in drastically different environments. Diabetes Care 1999;22(3):413-417
31. Wellhoener P, Fruehwald-Schultes B, Kern W, et al. Glucose metabolism rather than insulin is a main determinant of leptin secretion in humans. J Clin Endocrinol Metab 2000;85(3):1267-1271
32. Sonnenberg GE, Krakower GR, Hoffmann RG, et al. Plasma leptin concentrations during extended fasting and graded glucose infusions: relationships with changes in glucose, insulin, and FFA. J Clin Endocrinol Metab 2001;86(10):4895-4900
33. Koutkia P, Canavan B, Johnson ML, et al. Characterization of leptin pulse dynamics and relationship to fat mass, growth hormone, cortisol, and insulin. Am J Physiol Endocrinol Metab 2003;285(2):E372-9
34. Licinio J, Caglayan S, Ozata M, et al. Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci U S A 2004;101(13):4531-4536
35. Farooqi IS, Jebb SA, Langmack G, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999;341(12):879-884
36. Farooqi IS, Matarese G, Lord GM, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 2002;110(8):1093-1103
37. Rossetti L, Massillon D, Barzilai N, et al. Short term effects of leptin on hepatic gluconeogenesis and in vivo insulin action. J Biol Chem 1997;272(44):27758-27763
38. Liu L, Karkanias GB, Morales JC, et al. Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes. J Biol Chem 1998;273(47):31160-31167
39. Barzilai N, Wang J, Massilon D, et al. Leptin selectively decreases visceral adiposity and enhances insulin action. J Clin Invest 1997;100(12):3105-3110
40. Schwartz MW, Baskin DG, Bukowski TR, et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996;45(4):531-535
41. Kamohara S, Burcelin R, Halaas JL, et al. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 1997;389(6649):374-377
42. Wang JL, Chinookoswong N, Scully S, et al. Differential effects of leptin in regulation of tissue glucose utilization in vivo. Endocrinology 1999;140(5):2117-2124
43. Ceddia RB, William WN Jr, Curi R. Comparing effects of leptin and insulin on glucose metabolism in skeletal muscle: evidence for an effect of leptin on glucose uptake and decarboxylation. Int J Obes Relat Metab Disord 1999;23(1):75-82
44. Ceddia RB, William WN Jr, Curi R. Leptin increases glucose transport and utilization in skeletal muscle in vitro. Gen Pharmacol 1998;31(5):799-801
45. Harris RB. Acute and chronic effects of leptin on glucose utilization in lean mice. Biochem Biophys Res Commun 1998;245(2):502-509
46. Furnsinn C, Brunmair B, Furtmuller R, et al. Failure of leptin to affect basal and insulin-stimulated glucose metabolism of rat skeletal muscle in vitro. Diabetologia 1998;41(5):524-529
47. Zierath JR, Frevert EU, Ryder JW, et al. Evidence against a direct effect of leptin on glucose transport in skeletal muscle and adipocytes. Diabetes 1998;47(1):1-4
48. Campfield LA, Smith FJ, Guisez Y, et al. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269(5223):546-549
49. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995;269(5223):543-546
50. Kieffer TJ, Heller RS, Habener JF. Leptin receptors expressed on pancreatic β-cells. Biochem Biophys Res Commun 1996;224(2):522-527
51. Kieffer TJ, Habener JF. The adipoinsular axis: effects of leptin on pancreatic β-cells. Am J Physiol Endocrinol Metab 2000;278(1):E1-E14
52. Seufert J, Kieffer TJ, Leech CA, et al. Leptin suppression of insulin secretion and gene expression in human pancreatic islets: implications for the development of adipogenic diabetes mellitus. J Clin Endocrinol Metab 1999;84(2):670-676
53. Ahren B, Havel PJ. Leptin inhibits insulin secretion induced by cellular cAMP in a pancreatic B cell line (INS-1 cells). Am J Physiol 1999;277(4 Pt 2):R959-66
54. Lupi R, Marchetti P, Maffei M, et al. Effects of acute or prolonged exposure to human leptin on isolated human islet function. Biochem Biophys Res Commun 1999;256(3):637-641
55. Leclercq-meyer V, Considine RV, Sener A, et al. Do leptin receptors play a functional role in the endocrine pancreas? Biochem Biophys Res Commun 1996;229(3):794-798
56. Cases JA, Gabriely I, Ma XH, et al. Physiological increase in plasma leptin markedly inhibits insulin secretion in vivo. Diabetes 2001;50(2):348-352
57. Pallett AL, Morton NM, Cawthorne MA, et al. Leptin inhibits insulin secretion and reduces insulin mRNA levels in rat isolated pancreatic islets. Biochem Biophys Res Commun 1997;238(1):267-270
58. Laubner K, Kieffer TJ, Lam NT, et al. Inhibition of preproinsulin gene expression by leptin induction of suppressor of cytokine signaling 3 in pancreatic β-cells. Diabetes 2005;54(12):3410-3417
59. Howard JK, Flier JS. Attenuation of leptin and insulin signaling by SOCS proteins. Trends Endocrinol Metab 2006;17(9):365-371
60. Seufert J. Leptin effects on pancreatic β-cell gene expression and function. Diabetes 2004;53(Suppl 1):S152-8
61. Heymsfield SB, Greenberg AS, Fujioka K, et al. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 1999;282(16):1568-1575
62. Colombo C, Cutson JJ, Yamauchi T, et al. Transplantation of adipose tissue lacking leptin is unable to reverse the metabolic abnormalities associated with lipoatrophy. Diabetes 2002;51(9):2727-2733
63. Oral EA, Simha V, Ruiz E, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med 2002;346(8):570-578
64. Petersen KF, Oral EA, Dufour S, et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 2002;109(10):1345-1350
65. Simha V, Szczepaniak LS, Wagner AJ, et al. Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy. Diabetes Care 2003;26(1):30-35
66. Ebihara K, Masuzaki H, Nakao K. Long-term leptin-replacement therapy for lipoatrophic diabetes. N Engl J Med 2004;351(6):615-616
67. Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402(6762):656-660
68. Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000;141(11):4255-4261
69. Hofmann K. A superfamily of membrane-bound O-acyltransferases with implications for Wnt signaling. Trends Biochem Sci 2000;25(3):111-112
70. Yang J, Brown MS, Liang G, et al. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 2008;132(3):387-396
71. Gutierrez JA, Solenberg PJ, Perkins DR, et al. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci U S A 2008;105(17):6320-6325
72. Hosoda H, Kojima M, Mizushima T, et al. Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by post-translational processing. J Biol Chem 2003;278(1):64-70
73. van der Lely AJ, Tschop M, Heiman ML, et al. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 2004;25(3):426-457 · A complete review on the biology of ghrelin.
74. Ariyasu H, Takaya K, Tagami T, et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001;86(10):4753-4758
75. Djurhuus CB, Hansen TK, Gravholt C, et al. Circulating levels of ghrelin and GLP-1 are inversely related during glucose ingestion. Horm Metab Res 2002;34(7):411-413
76. Cummings DE, Purnell JQ, Frayo RS, et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001;50(8):1714-1719
77. Tschop M, Wawarta R, Riepl RL, et al. Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest 2001;24(6):RC19-21
78. Tolle V, Bassant MH, Zizzari P, et al. Ultradian rhythmicity of ghrelin secretion in relation with GH, feeding behavior, and sleep-wake patterns in rats. Endocrinology 2002;143(4):1353-1361
79. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000;407(6806):908-913
80. Overduin J, Frayo RS, Grill HJ, et al. Role of the duodenum and macronutrient type in ghrelin regulation. Endocrinology 2005;146(2):845-850
81. Howard AD, Feighner SD, Cully DF, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996;273(5277):974-977
82. Mckee KK, Palyha OC, Feighner SD, et al. Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors. Mol Endocrinol 1997;11(4):415-423
83. Nogueiras R, Perez-Tilve D, Wortley KE, et al. Growth hormone secretagogue (ghrelin-) receptors-a complex drug target for the regulation of body weight. CNS Neurol Disord Drug Targets 2006;5(3):335-343
84. Kamegai J, Wakabayashi I, Kineman RD, et al. Growth hormone-releasing hormone receptor (GHRH-R) and growth hormone secretagogue receptor (GHS-R) mRNA levels during postnatal development in male and female rats. J Neuroendocrinol 1999;11(4):299-306
85. Kamegai J, Tamura H, Ishii S, et al. Thyroid hormones regulate pituitary growth hormone secretagogue receptor gene expression. J Neuroendocrinol 2001;13(3):275-278
86. Tamura H, Kamegai J, Sugihara H, et al. Glucocorticoids regulate pituitary growth hormone secretagogue receptor gene expression. J Neuroendocrinol 2000;12(6):481-485
87. Petersenn S, Rasch AC, Penshorn M, et al. Genomic structure and transcriptional regulation of the human growth hormone secretagogue receptor. Endocrinology 2001;142(6):2649-2659
88. Bennett PA, Thomas GB, Howard AD, et al. Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression is regulated by growth hormone in the rat. Endocrinology 1997;138(11):4552-4557
89. Ghigo E, Arvat E, Broglio F, et al. Endocrine and non-endocrine activities of growth hormone secretagogues in humans. Horm Res 1999;51(Suppl 3):9-15
90. Cao JM, Ong H, Chen C. Effects of ghrelin and synthetic GH secretagogues on the cardiovascular system. Trends Endocrinol Metab 2006;17(1):13-18
91. Iglesias MJ, Pineiro R, Blanco M, et al. Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes. Cardiovasc Res 2004;62(3):481-488
92. Chen CY, Inui A, Asakawa A, et al. Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology 2005;129(1):8-25
93. Masuda Y, Tanaka T, Inomata N, et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun 2000;276(3):905-908
94. Camina JP. Cell biology of the ghrelin receptor. J Neuroendocrinol 2006;18(1):65-76
95. Granata R, Settanni F, Biancone L, et al. Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic β-cells and human islets: involvement of 3?,5?-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-kinase/Akt signaling. Endocrinology 2007;148(2):512-529
96. Sun Y, Wang P, Zheng H, et al. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci U S A 2004;101(13):4679-4684
97. Yada T, Dezaki K, Sone H, et al. Ghrelin regulates insulin release and glycemia: physiological role and therapeutic potential. Curr Diabetes Rev 2008;4(1):18-23
98. Sun Y, Asnicar M, Saha PK, et al. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab 2006;3(5):379-386
99. Penicaud L, Leloup C, Fioramonti X, et al. Brain glucose sensing: a subtle mechanism. Curr Opin Clin Nutr Metab Care 2006;9(4):458-462
100. Wang WG, Chen X, Jiang H, et al. Effects of ghrelin on glucose-sensing and gastric distension sensitive neurons in rat dorsal vagal complex. Regul Pept 2008;146(1-3):169-175
101. Mccowen KC, Maykel JA, Bistrian BR, et al. Circulating ghrelin concentrations are lowered by intravenous glucose or hyperinsulinemic euglycemic conditions in rodents. J Endocrinol 2002;175(2):R7-11
102. Saad MF, Bernaba B, Hwu CM, et al. Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 2002;87(8):3997-4000
103. Purnell JQ, Weigle DS, Breen P, et al. Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans. J Clin Endocrinol Metab 2003;88(12):5747-5752
104. Broglio F, Arvat E, Benso A, et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 2001;86(10):5083-5086
105. Dezaki K, Hosoda H, Kakei M, et al. Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in β-cells: implication in the glycemic control in rodents. Diabetes 2004;53(12):3142-3151
106. Dezaki K, Sone H, Yada T. Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis. Pharmacol Ther 2008;118(2):239-249
107. Heijboer AC, van den Hoek AM, Parlevliet ET, et al. Ghrelin differentially affects hepatic and peripheral insulin sensitivity in mice. Diabetologia 2006;49(4):732-738
108. Murata M, Okimura Y, Iida K, et al. Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. J Biol Chem 2002;277(7):5667-5674
109. Gauna C, Delhanty PJ, Hofland LJ, et al. Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes. J Clin Endocrinol Metab 2005;90(2):1055-1060
110. Barazzoni R, Bosutti A, Stebel M, et al. Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle. Am J Physiol Endocrinol Metab 2005;288(1):E228-35
111. Doi A, Shono T, Nishi M, et al. IA-2β, but not IA-2, is induced by ghrelin and inhibits glucose-stimulated insulin secretion. Proc Natl Acad Sci U S A 2006;103(4):885-890
112. Dezaki K, Kakei M, Yada T. Ghrelin uses Gαi2 and activates voltage-dependent K+ channels to attenuate glucose-induced Ca2+ signaling and insulin release in islet β-cells: novel signal transduction of ghrelin. Diabetes 2007;56(9):2319-2327
113. Shiau YS, Huang PT, Liou HH, et al. Structural basis of binding and inhibition of novel tarantula toxins in mammalian voltage-dependent potassium channels. Chem Res Toxicol 2003;16(10):1217-1225
114. Dezaki K, Sone H, Koizumi M, et al. Blockade of pancreatic islet-derived ghrelin enhances insulin secretion to prevent high-fat diet-induced glucose intolerance. Diabetes 2006;55(12):3486-3493
115. Gualillo O, Lago F, Dieguez C. Introducing GOAT: a target for obesity and anti-diabetic drugs? Trends Pharmacol Sci 2008;29(8):398-401 · An extensive a thoughtful opinion article about therapeutic potential of ghrelin system.